Nuvation Bio (NUVB) Debt Ratio (2024 - 2026)
Nuvation Bio (NUVB) posted quarterly Debt Ratio of 0.09 for Q1 2026, up 654.05% year-over-year from 0.01 in Q1 2025, and down 2.19% quarter-over-quarter from 0.09 in Q4 2025.
Nuvation Bio (NUVB) Debt Ratio (2024 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Debt Ratio for 3 consecutive years, with 0.09 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio rose 654.05% year-over-year to 0.09; the TTM figure through Mar 2026 stood at 0.09 (up 654.05% YoY), while the FY2025 annual figure was 0.09, up 665.7% from the prior year.
- Debt Ratio slipped to 0.09 in Q1 2026 per NUVB's latest filing, from 0.09 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.09 in Q4 2025 and bottomed at 0.01 in Q1 2025.
- Historically, Debt Ratio has averaged 0.05 across 3 years, with a median of 0.05 in 2024.
- On a YoY basis, Debt Ratio climbed as much as 665.7% in 2025 and fell as far as 315.16% in 2025.
- Nuvation Bio's Debt Ratio stood at 0.01 in 2024, then surged by 665.7% to 0.09 in 2025, then fell by 2.19% to 0.09 in 2026.
- Business Quant data shows NUVB's Debt Ratio at 0.09 in Q1 2026, 0.09 in Q4 2025, and 0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.33 |
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.02 |